Published in Q J Med on April 01, 1974
Acute neuromuscular respiratory paralysis. J Neurol Neurosurg Psychiatry (1993) 1.72
Animal models of peripheral neuropathy due to environmental toxicants. ILAR J (2014) 0.83
Occupational neurology. Yale J Biol Med (1987) 0.80
Thallium 201 scintigraphy. West J Med (1980) 0.75
Clinical and electrodiagnostic follow-up of an adolescent poisoned with thallium. Neurol Sci (2007) 0.75
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet (1997) 4.43
The significance of the "dying back" process in experimental and human neurological disease. Int Rev Exp Pathol (1964) 3.99
The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain (1987) 3.15
In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol (1990) 2.70
Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain (1990) 2.53
Superficial siderosis of the central nervous system. Brain (1995) 2.31
Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain (1988) 2.29
Paradoxical expansion of intracranial tuberculomas during chemotherapy. Lancet (1984) 2.19
Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology (2008) 2.06
Neurotoxic potential of gadodiamide after injection into the lateral cerebral ventricle of rats. AJNR Am J Neuroradiol (1998) 2.04
Tropical spastic paraparesis and human T cell lymphotropic virus type 1 in the United Kingdom. Brain (1989) 2.00
The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain (1998) 1.99
Antibody to human T-lymphotropic virus type 1 in West-Indian-born UK residents with spastic paraparesis. Lancet (1987) 1.92
The proliferation of astrocytes around a needle wound in the rat brain. J Anat (1970) 1.80
Mitochondrial encephalomyopathies: biochemical studies in two cases revealing defects in the respiratory chain. Brain (1982) 1.80
Unusual case of mercury poisoning. Br Med J (1967) 1.79
Vascular leakage in the dorsal root ganglia of the rat, studied with horseradish peroxidase. J Neurol Sci (1976) 1.71
Neurological complications in Behçet's syndrome. Brain (1999) 1.68
Treatment of periodic alternating nystagmus. Ann Neurol (1980) 1.68
Interferon beta-1b. Lancet (1994) 1.64
Neurotoxic effects of gadopentetate dimeglumine: behavioral disturbance and morphology after intracerebroventricular injection in rats. AJNR Am J Neuroradiol (1996) 1.64
Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial. Neurology (1997) 1.60
The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency)--investigation of symptomatic and presymptomatic patients. Q J Med (1990) 1.60
Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology (1994) 1.60
The experimental neuropathy in rats caused by p-bromophenylacetylurea. J Neurol Neurosurg Psychiatry (1968) 1.59
The battered child syndrome. Med Sci Law (1966) 1.56
Dissociation of visual and haptic vertical in two patients with vestibular nuclear lesions. Neurology (2003) 1.55
Visual vertigo: symptom assessment, spatial orientation and postural control. Brain (2001) 1.47
Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Neurology (1990) 1.47
Screening for prolonged incubation of HTLV-I infection in British and Jamaican relatives of British patients with tropical spastic paraparesis. BMJ (1990) 1.45
Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS Res Hum Retroviruses (1992) 1.45
Peripheral neuropathy caused by chemical agents. CRC Crit Rev Toxicol (1973) 1.44
Convergence nystagmus associated with Arnold-Chiari malformation. Arch Neurol (1990) 1.44
Intraneural injection of diphtheria toxin. Br J Exp Pathol (1966) 1.44
New autonomic and sensory neuropathy with loss of adrenergic sympathetic function and sensory neuropeptides. Lancet (1991) 1.43
Type II Alzheimer change experimentally produced in astrocytes in the rat. J Neurol Sci (1971) 1.43
"Neuroaxonal dystrophy" occurring in an experimental "dying back" process in the rat. Brain (1969) 1.42
Oligoclonal immunoglobulins and plasma cells in spinal fluid of patients with multiple sclerosis. Br Med J (1979) 1.41
Multiparameter MR imaging in the 6-OPRI variant of inherited prion disease. AJNR Am J Neuroradiol (2013) 1.39
Brain biopsy in dementia. Brain (2005) 1.36
Abnormalities of the auditory evoked potentials in patients with multiple sclerosis. Brain (1977) 1.35
Tourniquet paralysis with prolonged conduction block. An electro-physiological study. J Bone Joint Surg Br (1974) 1.33
The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders. Brain (2001) 1.32
Late recurrences of Sydenham's chorea are not associated with anti-basal ganglia antibodies. J Neurol Neurosurg Psychiatry (2004) 1.32
Long-term retrograde amnesia...the crucial role of the hippocampus. Neuropsychologia (2001) 1.31
Primary position upbeating nystagmus. A variety of central positional nystagmus. Brain (1983) 1.30
Acute myelopathy associated with primary infection with human immunodeficiency virus. Br Med J (Clin Res Ed) (1987) 1.28
The 'dying back' process. A common denominator in many naturally occurring and toxic neuropathies. Arch Pathol Lab Med (1979) 1.27
Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Brain (1987) 1.27
Lymphocytic infiltration in gliomas: evidence of possible host resistance. Brain (1971) 1.25
Bilateral loss of vestibular function: clinical findings in 53 patients. J Neurol (1998) 1.25
Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Mult Scler (1995) 1.24
Ultrastructural responses of the astrocytes to portocaval anastomosis in the rat. J Neurol Sci (1973) 1.22
Positional down beating nystagmus in 50 patients: cerebellar disorders and possible anterior semicircular canalithiasis. J Neurol Neurosurg Psychiatry (2002) 1.21
Changes in blood vessel permeability during degeneration and regeneration in peripheral nerves. Brain (1968) 1.18
Brain stem encephalitis caused by Herpesvirus hominis. Br Med J (1972) 1.17
Ultrastructural changes in the region of the node of ranvier in the rat caused by diphtheria toxin. Brain (1969) 1.17
Magnetic resonance imaging in clinically isolated lesions of the brain stem. J Neurol Neurosurg Psychiatry (1986) 1.16
Aggregations of filaments in Schwann cells of spinal roots of the normal rat. J Neurocytol (1972) 1.15
Effects of chronic porto-caval anastomosis on brain tryptophan, tyrosine and 5-hydroxytryptamine. J Neurochem (1975) 1.14
MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis. Neuroradiology (1987) 1.14
Perfusion-fixation, colchicine and mitotic activity in the adult rat brain. J Anat (1969) 1.12
The effects of cisplatin on rat spinal ganglia: a study by light and electron microscopy and by morphometry. Acta Neuropathol (1986) 1.12
Auditory evoked responses in multiple sclerosis. Lancet (1975) 1.11
Fibrillary accumulations in oligodendrogial processes of rats subjected to protocaval anastomosis. J Neurol Sci (1971) 1.11
Hyperpathia in the central cervical cord syndrome. J Neurol Neurosurg Psychiatry (1973) 1.10
Studies on the early changes in acute isoniazid neuropathy in the rat. Acta Neuropathol (1979) 1.10
Torsional nystagmus. A neuro-otological and MRI study of thirty-five cases. Brain (1992) 1.10
The effects of methyl-mercury-dicyandiamide on the peripheral nerves and spinal cord of rats. Acta Neuropathol (1971) 1.09
Vestibular involvement in spasmodic torticollis. J Neurol Neurosurg Psychiatry (1986) 1.09
Double-blind controlled trial of immunosuppression in the treatment of multiple sclerosis: final report. Lancet (1982) 1.09
Late onset post-traumatic hypothalamic hypothermia. J Neurol Neurosurg Psychiatry (1983) 1.08
Effects of previous x-irradiation on the cellular response of nervous tissue to injury. Nature (1968) 1.08
Neuropathy target esterase: immunolocalization to neuronal cell bodies and axons. Neuroscience (1998) 1.08
Dendritic cells infected in vitro with human T cell leukaemia/lymphoma virus type-1 (HTLV-1); enhanced lymphocytic proliferation and tropical spastic paraparesis. Clin Exp Immunol (1993) 1.08
Spasmodic torticollis following unilateral VIII nerve lesions: neck EMG modulation in response to vestibular stimuli. J Neurol Neurosurg Psychiatry (1987) 1.07
Effects of x-irradiation on the proliferation of cells in peripheral nerve during Wallerian degeneration in the rat. Br J Radiol (1968) 1.07
Abnormalities of horizontal gaze. Clinical, oculographic and magnetic resonance imaging findings. I. Abducens palsy. J Neurol Neurosurg Psychiatry (1990) 1.07
Organophosphorous neuropathy. I. A teased-fiber study of the spatio-temporal spread of axonal degeneraion. Am J Pathol (1979) 1.07
Subacute sclerosing panencephalitis: rapidly progressive cognitive decline in a young patient. Br J Hosp Med (Lond) (2013) 1.07
Double-blind, controlled trial of immunosuppression in treatment of multiple sclerosis. Lancet (1980) 1.06
Species differences in internode formation following two types of peripheral nerve injury. J Anat (1969) 1.05
Organophosphorous neuropathy. II. A fine-structural study of the early stages of axonal degeneration. Am J Pathol (1979) 1.04
The pattern of recovery of axons in the nervous system of rats following 2,5-hexanediol intoxication: a question of rheology? Neuropathol Appl Neurobiol (1982) 1.04
On the mechanism of type I Alzheimer abnormality in the nuclei of astrocytes. An essay in quantitative histology. J Neurol Sci (1971) 1.03
Abnormalities of horizontal gaze. Clinical, oculographic and magnetic resonance imaging findings. II. Gaze palsy and internuclear ophthalmoplegia. J Neurol Neurosurg Psychiatry (1990) 1.03
The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord. Ann Neurol (1989) 1.03
A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psychiatry (1996) 1.02
Analysis of downbeat nystagmus. Otolithic vs semicircular canal influences. Arch Neurol (1986) 1.02
Progressive degeneration of the cerebral cortex in infancy. Brain (1968) 1.02
Toxic substances and the nervous system. Br Med Bull (1969) 1.02
Some effects of porto-caval anastomosis in the male rat. Br J Exp Pathol (1970) 1.01
Clinical and MRI correlates in 27 patients with acquired pendular nystagmus. Brain (1996) 1.01
Bilateral loss of vestibular function. Acta Otolaryngol Suppl (1995) 1.00
Loffler's eosinophilic endocarditis with Balint's syndrome (optic ataxia and paralysis of visual fixation). Q J Med (1971) 0.99
Testing the gate-control theory of pain in man. J Neurol Neurosurg Psychiatry (1974) 0.99
Bilateral lesions of CA1 and CA2 fields of the hippocampus are sufficient to cause a severe amnesic syndrome in humans. J Neurol Neurosurg Psychiatry (1995) 0.98
The pathokinetics of acrylamide intoxication: a reassessment of the problem. Neuropathol Appl Neurobiol (1982) 0.98
Oligodendroglial gliomatosis cerebri: (1)H-MRS suggests elevated glycine/inositol levels. Neuroradiology (1999) 0.98